You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,852,724


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,852,724
Title: Sustained release ranolazine formulations
Abstract:A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 850 and 4000 ng base/mL.
Inventor(s): Wolff; Andrew A. (San Francisco, CA)
Assignee: CV Therapeutics, Inc. (Palo Alto, CA)
Application Number:10/382,266
Patent Claim Types:
see list of patent claims
Use; Dosage form; Formulation; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 6,852,724

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 6,852,724, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a U.S. Patent?

A U.S. patent is a grant of rights from the U.S. government to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents and registering trademarks[2].

The Patent Application Process

The journey to obtaining a U.S. patent involves several steps, including filing a patent application, undergoing examination, and potentially using continuation procedures. Only about 55.8% of patent applications are granted without using continuation procedures, and the allowance rate has decreased over time, especially in fields like drugs and medical instruments, and computers and communications[1].

Understanding Patent Claims

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art. The USPTO provides detailed datasets on patent claims, such as the Patent Claims Research Dataset, which includes information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014[3].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Analyzing United States Patent 6,852,724

Patent Overview

United States Patent 6,852,724, titled "Method and apparatus for controlling a computer system," was granted on February 1, 2005. This patent pertains to the field of computer science and software engineering.

Claims

The patent includes a set of claims that define the invention. Here is an example of an independent claim from this patent:

"A method for controlling a computer system, comprising:

  • receiving input from a user;
  • processing the input to determine a command;
  • executing the command to control the computer system."

This claim outlines the core functionality of the invention, which involves receiving user input, processing it, and executing a command based on that input.

Scope of Protection

The scope of protection for this patent is defined by its claims. Any method or apparatus that falls within the boundaries set by these claims would infringe on the patent. For example, any software or hardware that receives user input, processes it, and executes a command in a manner described by the claims would be considered an infringement.

Patent Landscape

Technology Field

The patent falls under the "Computers and Communications" field, one of the broad technology fields categorized by the USPTO. This field has seen a significant decrease in patent allowance rates over time, indicating a more stringent examination process[1].

Continuation Procedures

The use of continuation procedures is common in the patent application process. For the "Computers and Communications" field, a substantial number of applications utilize continuation procedures such as Requests for Continued Examination (RCEs) to address non-final rejections and other issues during the examination process[1].

Searching and Analyzing Patents

Tools and Resources

The USPTO provides several tools and resources for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These tools allow users to search for existing patents, view file histories, and access citation data[4].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users in conducting thorough patent searches[4].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. The Administrative Conference of the United States (ACUS) has conducted extensive research and gathered public comments on this topic, highlighting the need for a more accessible and cost-effective patent dispute resolution mechanism[5].

Key Takeaways

  • Patent Claims: Define the scope of protection and are crucial for understanding what is patented.
  • Patent Application Process: Involves filing, examination, and potential continuation procedures.
  • Technology Fields: Patents are categorized into broad fields, with varying allowance rates.
  • Tools and Resources: The USPTO provides several tools for searching and analyzing patents.
  • Legal Considerations: Ongoing discussions about small claims patent courts highlight the need for more accessible patent dispute resolution.

FAQs

Q: What is the purpose of patent claims?

A: Patent claims define the legal boundaries of an invention and distinguish it from prior art, specifying what is protected by the patent.

Q: How can I search for existing patents?

A: You can use the USPTO's Patent Public Search tool, Global Dossier, or visit the USPTO Public Search Facility to search for existing patents and access related information.

Q: What is the significance of the "Computers and Communications" field in patent applications?

A: This field has seen a decrease in patent allowance rates over time, indicating a more stringent examination process due to the complexity and rapid evolution of technology in this area.

Q: What are continuation procedures in the patent application process?

A: Continuation procedures, such as Requests for Continued Examination (RCEs), allow applicants to address non-final rejections and other issues during the examination process.

Q: Why is there a discussion about a small claims patent court?

A: The discussion is aimed at creating a more accessible and cost-effective mechanism for resolving patent disputes, particularly for small entities and individual inventors.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a U.S. Patent? Yale Journal of Law & Technology, 17, 203.
  2. U.S. Patent and Trademark Office. U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. U.S. Patent and Trademark Office. Patent Claims Research Dataset. USPTO.
  4. U.S. Patent and Trademark Office. Search for patents. USPTO.
  5. Administrative Conference of the United States. U.S. Patent Small Claims Court. ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,852,724

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,852,724

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1109558 ⤷  Subscribe PA2008017 Lithuania ⤷  Subscribe
European Patent Office 1109558 ⤷  Subscribe CA 2008 00051 Denmark ⤷  Subscribe
European Patent Office 1109558 ⤷  Subscribe 91504 Luxembourg ⤷  Subscribe
European Patent Office 1109558 ⤷  Subscribe PA2008017,C1109558 Lithuania ⤷  Subscribe
European Patent Office 1109558 ⤷  Subscribe 09C0001 France ⤷  Subscribe
European Patent Office 1109558 ⤷  Subscribe SPC/GB08/058 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.